BSEINDIA Beta Notices Media Release Trading Holidays BSEPlus Contact Us
हिन्दी     मराठी     ગુજરાતી


Print this Form
Notices
Notice No20180214-7Notice Date14 Feb 2018
CategoryCorporate ActionsSegmentEquity
SubjectTrading and Settlement of Trades in Dematerialised Securities
Content

 

Trading and Settlement of Trades in Dematerialised Securities
 
Trading Members are hereby informed that Sarda Proteins Ltd. (scrip code: 519242) has signed the agreement with both the Depositories.
 
In this regard, the modalities for settlement of trades executed in the scrip of the Company w.e.f.  Friday, February  16, 2018 (Sett. No. DR-221/2017-2018) would be as follows:
 
  1.   The scrip would continue to be traded in Trade to Trade Segment for reasons other than non-signing of agreements with depositories. However the trades in scrip would be required to be settled in compulsory demat form.
  2.    All trades executed in the scrip would be in market lot of 1 equity share
  3.    Netting will not be allowed in the scrip.
  4.   Shortages in the scrip would be directly closed-out.
Trading Members are also requested to note the revised Group & Market Lot of the security of the Company as follows:
 

Sr.
Scrip Code
Scrip Name
Current Group
Revised Group
Current Market Lot
Revised Market Lot
1
519242
Sarda Proteins Ltd.
P
XT
100
1

 
 
In case of any query / clarification, Trading Members may please contact :
 

Sr. No.
Name of the Officer
Telephone No
1
Mr. Marian Dsouza
022-2272 8744
2
Mr. Amol Hosalkar
022 -2272 8390

 
 
 
Mangesh Tayde                                                                                                        
Senior Manager
022 – 2272 8846